• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞通过分泌骨形态发生蛋白7抑制转化生长因子-β信号通路,在体内和体外改善糖尿病性肾小球纤维化。

Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7.

作者信息

Lv Shasha, Liu Gang, Sun Aili, Wang Jianping, Cheng Jing, Wang Weiwei, Liu Xiangchun, Nie Huibin, Guan Guangju

机构信息

Nephrology Research Institute of Shandong University, The Second Hospital of Shandong University, Shandong University, Jinan, People's Republic of China.

Department of Endocrinology, The Second Hospital of Shandong University, Shandong University, Jinan, People's Republic of China.

出版信息

Diab Vasc Dis Res. 2014 Jul;11(4):251-261. doi: 10.1177/1479164114531300. Epub 2014 May 19.

DOI:10.1177/1479164114531300
PMID:24845071
Abstract

PURPOSE

To investigate whether mesenchymal stem cells (MSCs) could inhibit transforming growth factor beta (TGF-β) signalling pathway by paracrine action.

METHODS

Bone marrow-derived MSCs were transplanted to streptozotocin-induced diabetic rats via tail vein. MSC-conditioned media were used with a model of mesangial cell fibrosis induced by high glucose in vitro.

RESULTS

At 8 weeks after MSC treatment, the renal function and the glomerulosclerosis as revealed by periodic acid Schiff stain was dramatically attenuated. The expression of collagen I, collagen IV and α-smooth muscle actin (SMA) in diabetic kidney was decreased, and E-cadherin increased after MSC treatment. The TGF-β signalling pathway was suppressed both in vivo and in vitro. MSCs secreted a significant amount of bone morphogenetic protein 7 (BMP7), in vitro, MSC-conditioned media inhibited TGF-β signalling stimulated by high glucose, and BMP7 neutralizing antibody blocked the inhibitory effect of MSC-conditioned media.

CONCLUSION

MSCs ameliorated glomerular fibrosis in vivo and in vitro by inhibiting TGF-β/Smad signalling pathway via secretion of BMP7.

摘要

目的

研究间充质干细胞(MSCs)是否可通过旁分泌作用抑制转化生长因子β(TGF-β)信号通路。

方法

将骨髓来源的MSCs经尾静脉移植到链脲佐菌素诱导的糖尿病大鼠体内。将MSCs条件培养基用于体外高糖诱导的系膜细胞纤维化模型。

结果

MSC治疗8周后,肾功能以及经高碘酸希夫染色显示的肾小球硬化显著减轻。糖尿病肾脏中I型胶原、IV型胶原和α-平滑肌肌动蛋白(SMA)的表达降低,而E-钙黏蛋白在MSC治疗后增加。TGF-β信号通路在体内和体外均受到抑制。MSCs分泌大量骨形态发生蛋白7(BMP7),体外,MSCs条件培养基抑制高糖刺激的TGF-β信号通路,且BMP7中和抗体阻断了MSCs条件培养基的抑制作用。

结论

MSCs通过分泌BMP7抑制TGF-β/Smad信号通路,在体内和体外改善肾小球纤维化。

相似文献

1
Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7.间充质干细胞通过分泌骨形态发生蛋白7抑制转化生长因子-β信号通路,在体内和体外改善糖尿病性肾小球纤维化。
Diab Vasc Dis Res. 2014 Jul;11(4):251-261. doi: 10.1177/1479164114531300. Epub 2014 May 19.
2
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress.间充质干细胞移植通过抑制氧化应激改善链脲佐菌素诱导的大鼠糖尿病肾病中的肾小球损伤。
Diabetes Res Clin Pract. 2014 Apr;104(1):143-54. doi: 10.1016/j.diabres.2014.01.011. Epub 2014 Jan 14.
3
Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.人脐带血源间充质干细胞通过旁分泌作用预防糖尿病肾损伤。
Diabetes Res Clin Pract. 2012 Dec;98(3):465-73. doi: 10.1016/j.diabres.2012.09.034. Epub 2012 Sep 29.
4
Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy.血管紧张素转换酶 2 修饰的间充质干细胞改善糖尿病肾病肾小球纤维化的作用更优。
Diabetes Res Clin Pract. 2020 Apr;162:108093. doi: 10.1016/j.diabres.2020.108093. Epub 2020 Feb 25.
5
Icariin attenuates high glucose-induced type IV collagen and fibronectin accumulation in glomerular mesangial cells by inhibiting transforming growth factor-β production and signalling through G protein-coupled oestrogen receptor 1.淫羊藿素通过抑制 G 蛋白偶联雌激素受体 1 抑制转化生长因子-β的产生和信号转导,减轻高糖诱导的肾小球系膜细胞型 IV 胶原和纤维连接蛋白的积累。
Clin Exp Pharmacol Physiol. 2013 Sep;40(9):635-43. doi: 10.1111/1440-1681.12143.
6
Mesenchymal stem cells suppress fibroblast proliferation and reduce skin fibrosis through a TGF-β3-dependent activation.间充质干细胞通过转化生长因子-β3依赖性激活来抑制成纤维细胞增殖并减轻皮肤纤维化。
Int J Low Extrem Wounds. 2015 Mar;14(1):50-62. doi: 10.1177/1534734614568373.
7
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.间质干细胞移植通过抑制巨噬细胞浸润改善链脲佐菌素诱导的糖尿病肾病大鼠的肾小球损伤。
Int Immunopharmacol. 2013 Oct;17(2):275-82. doi: 10.1016/j.intimp.2013.05.031. Epub 2013 Jun 19.
8
Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.BAMBI 抑制 TGF-β/Smad 信号通路可阻止人骨髓间充质干细胞向癌相关成纤维细胞分化,并消除其促肿瘤作用。
Stem Cells. 2012 Dec;30(12):2810-9. doi: 10.1002/stem.1251.
9
GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.肿瘤细胞分泌的 GRP78 可刺激骨髓间充质干细胞向癌相关成纤维细胞分化。
Biochem Biophys Res Commun. 2013 Nov 1;440(4):558-63. doi: 10.1016/j.bbrc.2013.09.108. Epub 2013 Oct 7.
10
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.预处理间充质干细胞与转化生长因子-α可改善间充质干细胞介导的心脏保护作用。
Shock. 2010 Jan;33(1):24-30. doi: 10.1097/SHK.0b013e3181b7d137.

引用本文的文献

1
Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease.间充质干细胞在减轻糖尿病肾病细胞凋亡方面的应用进展
World J Diabetes. 2025 Jun 15;16(6):105711. doi: 10.4239/wjd.v16.i6.105711.
2
Molecular Therapeutics for Diabetic Kidney Disease: An Update.糖尿病肾病的分子治疗:最新进展。
Int J Mol Sci. 2024 Sep 19;25(18):10051. doi: 10.3390/ijms251810051.
3
How Stem and Progenitor Cells Can Affect Renal Diseases.干细胞和祖细胞如何影响肾脏疾病。
Cells. 2024 Aug 30;13(17):1460. doi: 10.3390/cells13171460.
4
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets.慢性肾脏病中的纤维化:病理生理学与治疗靶点
J Clin Med. 2024 Mar 25;13(7):1881. doi: 10.3390/jcm13071881.
5
Therapeutic potential of conditioned medium obtained from deferoxamine preconditioned umbilical cord mesenchymal stem cells on diabetic nephropathy model.去铁胺预处理脐带间充质干细胞条件培养液对糖尿病肾病模型的治疗潜力。
Stem Cell Res Ther. 2022 Sep 2;13(1):438. doi: 10.1186/s13287-022-03121-6.
6
Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.间充质干细胞在糖尿病肾病中的应用:机制、信号通路和临床前证据。
Mol Cell Biochem. 2022 Aug;477(8):2073-2092. doi: 10.1007/s11010-022-04421-4. Epub 2022 Apr 25.
7
Umbilical Cord-Derived Mesenchymal Stem Cells Improve TGF-β, α-SMA and Collagen on Erectile Dysfunction in Streptozotocin-Induced Diabetic Rats.脐带间充质干细胞改善链脲佐菌素诱导的糖尿病大鼠勃起功能障碍中的 TGF-β、α-SMA 和胶原。
Med Arch. 2022 Feb;76(1):4-11. doi: 10.5455/medarh.2022.76.4-11.
8
BMP-7 ameliorates partial epithelial-mesenchymal transition by restoring SnoN protein level via Smad1/5 pathway in diabetic kidney disease.骨形态发生蛋白-7通过Smad1/5信号通路恢复SnoN蛋白水平,从而改善糖尿病肾病中的部分上皮-间质转化。
Cell Death Dis. 2022 Mar 21;13(3):254. doi: 10.1038/s41419-022-04529-x.
9
Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.干细胞衍生和循环的外泌体 microRNAs 作为糖尿病肾病管理的新潜在工具。
Stem Cell Res Ther. 2022 Jan 24;13(1):25. doi: 10.1186/s13287-021-02696-w.
10
When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease.来源的重要性:不同来源间充质基质细胞在肾脏疾病临床转化中的特性
Front Med (Lausanne). 2021 Sep 20;8:728496. doi: 10.3389/fmed.2021.728496. eCollection 2021.